These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7756930

  • 1. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
    Severina IS.
    Vestn Ross Akad Med Nauk; 1995; (2):41-6. PubMed ID: 7756930
    [Abstract] [Full Text] [Related]

  • 2. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
    Severina IS.
    Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
    [Abstract] [Full Text] [Related]

  • 3. Soluble guanylate cyclase of platelets: function and regulation in normal and pathological states.
    Severina IS.
    Adv Enzyme Regul; 1992 Mar; 32():35-56. PubMed ID: 1353937
    [Abstract] [Full Text] [Related]

  • 4. Effect of nitroso complexes of some transition metals on the activity of soluble guanylate cyclase.
    Severina IS, Bussygina OG, Grigorjev NB.
    Biochem Int; 1992 Mar; 26(4):695-705. PubMed ID: 1351725
    [Abstract] [Full Text] [Related]

  • 5. Effect of carnosine on the activation of human platelet soluble guanylate cyclase by sodium nitroprusside and protoporphyrin IX.
    Severina IS, Busygina OG.
    Biochem Int; 1990 Nov; 22(3):455-65. PubMed ID: 1981669
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT, Ignarro LJ, Myers CB, Ohlstein EH, Ballot BA, Hyman AL, Kadowitz PJ.
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [Abstract] [Full Text] [Related]

  • 7. Role of heme in the regulation of human and rat platelet soluble guanylate cyclases.
    Severina IS, Busygina OG.
    Biochem Int; 1991 Apr; 23(6):1143-54. PubMed ID: 1683234
    [Abstract] [Full Text] [Related]

  • 8. [The role of carnosine in the function of soluble of guanylate cyclase].
    Severina IS, Busygina OG.
    Biokhimiia; 1992 Sep; 57(9):1330-6. PubMed ID: 1361362
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [Abstract] [Full Text] [Related]

  • 10. [Heme deficiency of soluble guanylate cyclase in rat platelets].
    Busygina OG, Severina IS.
    Biokhimiia; 1991 Mar; 56(3):487-93. PubMed ID: 1679351
    [Abstract] [Full Text] [Related]

  • 11. Carnosine as a regulator of soluble guanylate cyclase.
    Severina IS, Bussygina OG, Pyatakova NV.
    Biochemistry (Mosc); 2000 Jul; 65(7):783-8. PubMed ID: 10951096
    [Abstract] [Full Text] [Related]

  • 12. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
    Severina IS.
    Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
    [Abstract] [Full Text] [Related]

  • 13. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
    Severina IS.
    Vopr Med Khim; 2002 Jul; 48(1):4-30. PubMed ID: 12068497
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B, Grewe R, Loeschke K, Gerzer R.
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [Abstract] [Full Text] [Related]

  • 15. [Relation between human platelet aggregation and activation of soluble platelet guanylate cyclase].
    Chirkov IuIu, Tyshchuk IA, Severina IS.
    Vopr Med Khim; 1990 Feb; 36(4):57-60. PubMed ID: 1978441
    [Abstract] [Full Text] [Related]

  • 16. Increase in activating ability of human platelet guanylate cyclase during aggregation.
    Severina IS, Belushkina NN.
    Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
    [Abstract] [Full Text] [Related]

  • 17. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 18. [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
    Severina IS.
    Biull Eksp Biol Med; 1995 Mar 15; 119(3):230-5. PubMed ID: 7795182
    [No Abstract] [Full Text] [Related]

  • 19. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
    Chirkov YY, Belushkina NN, Tyshchuk IA, Severina IS, Horowitz JD.
    Clin Exp Pharmacol Physiol; 1991 Jul 15; 18(7):517-24. PubMed ID: 1680588
    [Abstract] [Full Text] [Related]

  • 20. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation.
    Craven PA, DeRubertis FR.
    J Biol Chem; 1978 Dec 10; 253(23):8433-43. PubMed ID: 30778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.